Loading…

Exploration of Chlorella sp. as antibacterial to Aggregatibacter actinomycetemcomitans biofilm

Aggregatibacter actinomycetemcomitans is a facultative anaerobic gram-negative, which is major pathogenic bacteria cause of aggressive periodontitis that has the ability to form biofilm. The therapy of aggressive periodontitis has been done with tetracycline antibiotics, meanwhile it may cause resis...

Full description

Saved in:
Bibliographic Details
Published in:IOP conference series. Earth and environmental science 2019-01, Vol.217 (1), p.12040
Main Authors: Christabel, P F, Hernando, M V, Sutanto, C A, Parisihni, K
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aggregatibacter actinomycetemcomitans is a facultative anaerobic gram-negative, which is major pathogenic bacteria cause of aggressive periodontitis that has the ability to form biofilm. The therapy of aggressive periodontitis has been done with tetracycline antibiotics, meanwhile it may cause resistance problem. Chlorella sp. has antimicrobial activity against the anaerobic gram-negative bacteria as an adjunctive therapy of aggressive periodontitis. Purpose: This study aimed to determine the antibacterial potency of various concentrations of Chlorella sp. to A actinomycetemcomitans biofilm. Method: The antibacterial potency of Chlorella sp. to A actinomycetemcomitans were examined by biofilm test, divided into 5 groups, each group consisted of 4 samples. The control groups were: K− (aquadest), K+ (tetracycline), and treatment groups were given Chlorella sp. in various concentrations: P1 (0.625%), P2 (1.25%), and P3 (2.5%). The inhibition of biofilm formation were examined on microtiter plate by measure its Optical Density (OD) value on ELISA Reader. Data were analyzed using One Way ANOVA followed by LSD test. Result: Treatment with Chlorella sp in all treatment groups decreased the OD value, as well with tetracycline (p
ISSN:1755-1307
1755-1315
1755-1315
DOI:10.1088/1755-1315/217/1/012040